{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Lack of serologic tests for COVID-19\",\"Impact\":\"Difficulty in identifying and tracking the spread of the virus, leading to potential uncontrolled transmission\",\"Mitigation\":\"Develop serologic tests to accurately diagnose and monitor COVID-19 cases\",\"Technologies\":\"Diagnostic testing technologies\",\"People\":\"General population, healthcare workers, public health authorities\",\"Owner\":\"Health organizations, research institutions, government agencies\"},{\"Description\":\"Lack of specific treatments and vaccines for coronavirus infections\",\"Impact\":\"Increased severity of illness and higher mortality rates due to lack of effective medical interventions\",\"Mitigation\":\"Accelerate research and development of specific treatments and vaccines for coronavirus infections\",\"Technologies\":\"Biopharmaceutical development, vaccine production technologies\",\"People\":\"Patients with coronavirus infections, healthcare workers, public health authorities\",\"Owner\":\"Pharmaceutical companies, research institutions, government agencies\"},{\"Description\":\"Use of experimental and unapproved drugs for COVID-19 treatment\",\"Impact\":\"Potential risks of adverse reactions, drug ineffectiveness, and lack of standardized treatment protocols\",\"Mitigation\":\"Conduct rigorous clinical trials and research to assess the safety and efficacy of experimental drugs for COVID-19 treatment\",\"Technologies\":\"Clinical trial management systems, drug safety monitoring technologies\",\"People\":\"COVID-19 patients, healthcare workers, researchers\",\"Owner\":\"Research institutions, pharmaceutical companies, regulatory agencies\"}]}"}}